PREVALENCE OF CARDIOVASCULAR DISEASE BY VASCULAR BED IN TYPE 2 DIABETES POPULATION IN A REAL-WORLD SETTING

被引：0
|
作者：
Weng, Wayne [1 ]
Kong, Sheldon [1 ]
Ganguly, Rahul [1 ]
Hersloev, Malene [1 ]
Brett, Jason [1 ]
Hobbs, Todd [1 ]
Baeres, Florian M. M. [1 ]
机构：
[1] Novo Nordisk Inc, Plainsboro, NJ USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2019年 / 73卷 / 09期
关键词：
D O I：
10.1016/S0735-1097(19)32365-4
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1178-413
引用
收藏
页码：1759 / 1759
页数：1
相关论文
共 50 条
  • [1] The prevalence of cardiovascular disease by vascular bed and impact on healthcare costs in a large, real-world population with type 2 diabetes
    Weng, Wayne
    Kong, Sheldon X.
    Ganguly, Rahul
    Hersloev, Malene
    Brett, Jason
    Hobbs, Todd
    Baeres, Florian M. M.
    ENDOCRINOLOGY DIABETES & METABOLISM, 2020, 3 (02)
  • [2] Prevalence of cardiovascular disease and treatment pattern in patients with type 2 diabetes in a real world setting
    Weng, W.
    Tian, Y.
    Kong, X.
    Ganguly, R.
    Hersloev, M.
    Brett, J.
    Hobbs, T.
    DIABETOLOGIA, 2018, 61 : S136 - S136
  • [3] REAL-WORLD EVIDENCE OF PREVALENCE OF CARDIOVASCULAR DISEASE AMONGST TREATED DIABETES POPULATION IN 2016
    Khamis, Z. J.
    Merali, T.
    VALUE IN HEALTH, 2017, 20 (05) : A163 - A163
  • [4] Transposition of cardiovascular outcome trial effects to the real-world population of patients with type 2 diabetes
    V. Sciannameo
    P. Berchialla
    A. Avogaro
    G. P. Fadini
    Cardiovascular Diabetology, 20
  • [5] Transposition of cardiovascular outcome trial effects to the real-world population of patients with type 2 diabetes
    Sciannameo, V
    Berchialla, P.
    Avogaro, A.
    Fadini, G. P.
    CARDIOVASCULAR DIABETOLOGY, 2021, 20 (01)
  • [6] Longitudinal analysis of atherosclerotic cardiovascular disease risk and healthcare costs in newly diagnosed type 2 diabetes in a real-world setting
    Weng, W.
    Liang, Y.
    Brett, J.
    Hobbs, T.
    Baeres, F. M. M.
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2020, 34 (05)
  • [7] Impact of atherosclerotic cardiovascular disease on healthcare resource utilization and costs in patients with type 2 diabetes mellitus in a real-world setting
    Wayne Weng
    Ye Tian
    Sheldon X. Kong
    Rahul Ganguly
    Malene Hersloev
    Jason Brett
    Todd Hobbs
    Clinical Diabetes and Endocrinology, 6 (1):
  • [8] Clinical Characteristics of SGLT2 Inhibitor User in Type 2 Diabetes with Atherosclerotic Cardiovascular Disease or Heart Failure in a Real-World Setting
    Jeong, Su Jin
    Park, Ie Byung
    Lee, Seung Eun
    Shin, Donghyun
    Kim, Kyoung-Ah
    DIABETES, 2019, 68
  • [9] Rates of glycaemic deterioration in a real-world population with type 2 diabetes
    Donnelly, Louise A.
    Zhou, Kaixin
    Doney, Alex S. F.
    Jennison, Chris
    Franks, Paul W.
    Pearson, Ewan R.
    DIABETOLOGIA, 2018, 61 (03) : 607 - 615
  • [10] Rates of glycaemic deterioration in a real-world population with type 2 diabetes
    Louise A. Donnelly
    Kaixin Zhou
    Alex S. F. Doney
    Chris Jennison
    Paul W. Franks
    Ewan R. Pearson
    Diabetologia, 2018, 61 : 607 - 615
12345